olivlawolivlaw

olivLaw · US equity research

HWH International Inc. ESYN

Wholesale-Drugs, Proprietaries & Druggists' Sundries · SIC 5122 · Vertical: Wholesale-Drugs, Proprietaries & Druggists' Sundries (SIC 5122)

1.50USD−9.09% · 1 dayClose 04 Nov 2026

HWH International is a small company that operates, in essence, a single café in Singapore and is developing the Hapi Marketplace e-commerce platform and the Hapi Wealth Builder education program. Revenue fell sharply in 2025 after several cafés were closed, and the company relies on funding from its majority shareholder, which raises questions about continuity of operations.

At the close of 04 Nov 2026, HWH International Inc. (ESYN) stock was 1.50 USD (−9.09% on the day), with market capitalisation 11.6 m USD, beta 0.34, 52-week range 0.92–2.68 USD. Latest reported quarter (Q2 2026): revenue of 64.2 k USD (−79.3% YoY), net income of 212.0 k USD (+154.2% YoY), diluted EPS 0.03 USD.

Data as of · AI analysis dated · Source: SEC filings and closing prices, computed by olivLaw.

Market cap
11.6 m USD
shares as of 30 Jul 2026
P/E (TTM)
unavailable
Diluted EPS TTM -0.40 · TTM to 31 Dec 2025
E/P (TTM)
-26.67%
TTM to 31 Dec 2025
Dividend yield
unavailable
Beta (2y)
0.34
Volatility (1y) 109%
52-week range
0.922.68

Price history

Loading chart…

Technical reading

RSI (14)
34.3
weak (30–45)
Bollinger (20, 2)
1.50 – 2.16
in the lower half of the band · %B 0.00 · band width 36.4%
SMA 50 / 200
2.01 / 1.53
mixed trend
MACD (12, 26, 9)
-0.12 / -0.10
MACD below signal

Indicators describe past prices; on their own they do not predict direction. On our history the RSI ≤ 40 filter added no return (see the signals methodology).

Performance

CompanyS&P 500vs S&P 500Vertical median
1 month−29.2%−1.1%−28.1 pp—
3 months+3.4%−0.5%+3.9 pp—
6 months+41.5%+4.4%+37.1 pp—
Year to date+0.7%+12.3%−11.6 pp—
1 year−17.1%+13.5%−30.7 pp+8.1%
3 years−97.2%+76.4%−173.6 pp+46.5%
5 yearsunavailable+63.7%unavailable—
Max drawdown (1y)
−64.3%
10 Dec 2025 → 30 Mar 2026
Max drawdown (5y)
−98.4%
25 Jul 2023 → 30 Mar 2026
Compound annual growth (5y)
unavailable
S&P 500 +10.4%

Price returns, dividends excluded.

Quarterly results

Latest quarter: Q2 2026 · 30 Jun 2026

Revenue
64.2 k USD
−79.3% YoY
Net income
212.0 k USD
+154.2% YoY
Diluted EPS
0.03
+200.0% YoY
net / operating
330.2% / unavailable

Quarterly margins

Quarterly statements · USD

Fiscal yearQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Revenue345.5 k287.1 k295.2 k310.4 k206.8 k54.6 k64.2 k64.2 k
Cost of revenue185.7 k173.3 k147.6 k266.3 k83.2 k14.9 k16.9 k43.8 k
Gross profit159.9 k113.8 k147.6 k44.1 k123.6 k39.7 k47.3 k20.4 k
Depreciation & amortisation15.3 k2.6 k3.3 k3.4 k16.2 k-3.4 k2.1 k2.0 k
Interest expense18.5 k16.8 k50.1 k29.5 k32.1 k-59.5 k9.1 k2.3 k
Pre-tax income-537.1 k-488.5 k-531.2 k76.0 k-295.1 k-1.9 m-626.8 k210.7 k
Income tax——42.9 k0 ≈4.5 k0——
Net income-548.5 k-476.7 k-565.1 k83.4 k-291.0 k-1.9 m-626.2 k212.0 k
Diluted EPS——-0.090.01——-0.080.03
Operating cash flow-275.0 k ≈-415.2 k-555.3 k26.9 k ≈-199.9 k ≈-1.0 m-192.5 k478.0 k ≈
Capex2.1 k ≈291——18.0 k ≈87766-2 ≈
Share repurchases0 ≈1——————

≈ derived quarter (cumulative difference / share-days average)

E/P over time

E/P = trailing-12-month diluted EPS / price at quarter end. E/P is the inverse of P/E and stays defined when earnings are negative.

Fiscal years

Fiscal year2022202320242025
Revenueunavailableunavailable1.3 m866.9 k
Revenue YoYunavailableunavailableunavailable−30.8%
Net income113.5 k548.9 k-2.7 m-2.6 m
Net income YoYunavailable+383.4%−601.0%unavailable
Diluted EPSunavailableunavailable-0.76-0.40
Diluted EPS YoYunavailableunavailableunavailableunavailable
net %unavailableunavailable-219.4%-303.4%
Free cash flowunavailableunavailable-1.8 m-1.8 m

Reported results vs expectations

Loading…

Balance sheet & financial health

Fiscal year 2025 · 31 Dec 2025

Cash
2.1 m USD
Financial debt
unavailable USD
Net debt
unavailable USD
Equity
2.7 m USD
Total assets
4.6 m USD
Debt / equity
unavailable
Current ratio
2.32x
ROE
-94.6%
ROA
-47.9%
FCF margin
-204.1%

Financial statements (source on every figure)

Revenue and net income (USD)

Margins

Income statement · USD

Revenue
2023
—
2024
1.3 m
2025
866.9 k

SEC (XBRL)· 26 Mar 2026verified

Cost of revenue
2023
—
2024
651.7 k
2025
407.2 k

SEC (XBRL)· 26 Mar 2026verified

Gross profit
2023
—
2024
601.9 k
2025
459.7 k

SEC (XBRL)· 26 Mar 2026verified

Depreciation & amortisation
2023
—
2024
48.2 k
2025
19.5 k

SEC (XBRL)· 26 Mar 2026verified

Interest expense
2023
—
2024
72.1 k
2025
52.2 k

SEC (XBRL)· 26 Mar 2026verified

Pre-tax income
2023
971.1 k
2024
-2.8 m
2025
-2.6 m

SEC (XBRL)· 26 Mar 2026verified

Income tax
2023
422.2 k
2024
—
2025
47.5 k

SEC (XBRL)· 26 Mar 2026verified

Net income
2023
548.9 k
2024
-2.7 m
2025
-2.6 m

SEC (XBRL)· 26 Mar 2026verified

Diluted EPS
2023
—
2024
-0.76
2025
-0.40

SEC (XBRL)· 26 Mar 2026verified

Weighted average diluted shares
2023
—
2024
3.6 m
2025
6.6 m

SEC (XBRL)· 26 Mar 2026verified

Balance sheet · USD

Cash
2023
—
2024
4.3 m
2025
2.1 m

SEC (XBRL)· 26 Mar 2026verified

Inventories
2023
—
2024
1.6 k
2025
1.1 k

SEC (XBRL)· 26 Mar 2026verified

Current assets
2023
703.2 k
2024
5.5 m
2025
3.0 m

SEC (XBRL)· 26 Mar 2026verified

Property, plant & equipment, net
2023
—
2024
33.6 k
2025
19.2 k

SEC (XBRL)· 26 Mar 2026verified

Goodwill
2023
—
2024
0
2025
116.6 k

SEC (XBRL)· 26 Mar 2026verified

Total assets
2023
22.0 m
2024
6.4 m
2025
4.6 m

SEC (XBRL)· 26 Mar 2026verified

Accounts payable
2023
632.3 k
2024
483.4 k
2025
305.0 k

SEC (XBRL)· 26 Mar 2026verified

Current liabilities
2023
837.6 k
2024
3.3 m
2025
1.3 m

SEC (XBRL)· 26 Mar 2026verified

Total liabilities
2023
3.9 m
2024
—
2025
—

SEC (XBRL)· 28 Feb 2024verified

Equity
2023
-2.4 m †
2024
2.9 m
2025
2.7 m

SEC (XBRL)· 26 Mar 2026verified

Cash flow · USD

Operating cash flow
2023
-1.5 m
2024
-1.8 m
2025
-1.8 m

SEC (XBRL)· 26 Mar 2026verified

Capex
2023
—
2024
30.4 k
2025
19.5 k

SEC (XBRL)· 26 Mar 2026verified

Free cash flow
2023
—
2024
-1.8 m ≈
2025
-1.8 m ≈

SEC (XBRL)· 26 Mar 2026derived

Investing cash flow
2023
69.1 m
2024
20.5 m
2025
-1.2 m

SEC (XBRL)· 26 Mar 2026verified

Financing cash flow
2023
-68.1 m
2024
-15.6 m
2025
934.7 k

SEC (XBRL)· 26 Mar 2026verified

Share repurchases
2023
68.4 m
2024
21.1 m
2025
—

SEC (XBRL)· 31 Mar 2025verified

Computed indicators

Growth

Revenue growth (YoY)
-30.8%
computed by olivLawFY 2025
Revenue CAGR 3Y
unavailable
input data missing
Revenue CAGR 5Y
unavailable
input data missing
EBIT growth (YoY)
unavailable
input data missing
Net income growth (YoY)
unavailable
the base of the ratio is not positive
Net income CAGR 3Y
unavailable
the base of the ratio is not positive
Net income CAGR 5Y
unavailable
input data missing
EPS growth (YoY)
unavailable
the base of the ratio is not positive
EPS CAGR 3Y
unavailable
input data missing
EPS CAGR 5Y
unavailable
input data missing
FCF growth (YoY)
unavailable
the base of the ratio is not positive

Profitability

Gross margin
59.2%
computed by olivLawTTM to 30 Jun 2026
EBITDA margin
unavailable
input data missing
EBIT margin
unavailable
input data missing
Net margin
-680.0%
computed by olivLawTTM to 30 Jun 2026
FCF margin
-245.1%
computed by olivLawTTM to 30 Jun 2026

Returns

ROE
-88.9%
computed by olivLawTTM to 30 Jun 2026 · balance sheet at 30 Jun 2026
ROA
-35.1%
computed by olivLawTTM to 30 Jun 2026 · balance sheet at 30 Jun 2026
ROIC
unavailable
input data missing
ROCE
unavailable
input data missing
Payout ratio (EPS)
unavailable
input data missing
Payout ratio (FCF)
unavailable
input data missing

Balance sheet

Net debt
unavailable
input data missing
Net debt / EBITDA
unavailable
input data missing
Debt / equity
unavailable
input data missing
Interest coverage
unavailable
input data missing

Liquidity

Current ratio
1.8x
computed by olivLawbalance sheet at 30 Jun 2026
Quick ratio
1.8x
computed by olivLawbalance sheet at 30 Jun 2026
Cash ratio
0.9x
computed by olivLawbalance sheet at 30 Jun 2026

Cash

Operating cash flow
-936.4 k USD
computed by olivLawTTM to 30 Jun 2026
Capital expenditure
18.9 k USD
computed by olivLawTTM to 30 Jun 2026
Free cash flow
-955.3 k USD
computed by olivLawTTM to 30 Jun 2026
FCF conversion
unavailable
insufficient data
Cash conversion
unavailable
input data missing

Efficiency

Days sales outstanding
unavailable
input data missing
Days inventory outstanding
9 days
computed by olivLawTTM to 30 Jun 2026 · balance sheet at 30 Jun 2026
Days payables outstanding
858 days
computed by olivLawTTM to 30 Jun 2026 · balance sheet at 30 Jun 2026
Cash conversion cycle
unavailable
input data missing

Market and valuation

Market capitalisation
11.6 m USD
computed by olivLawbalance sheet at 30 Jun 2026
Enterprise value
unavailable
input data missing
Market cap / net income TTM
unavailable
insufficient data
P/E (TTM)
unavailable
insufficient data
Earnings yield
-22.9%
computed by olivLawTTM to 30 Jun 2026
P/B
4.2x
computed by olivLawbalance sheet at 30 Jun 2026
P/S
29.7x
computed by olivLawTTM to 30 Jun 2026 · balance sheet at 30 Jun 2026
EV/EBITDA
unavailable
input data missing
EV/EBIT
unavailable
input data missing
EV/Sales
unavailable
input data missing
P/FCF
unavailable
the base of the ratio is not positive
FCF yield
-8.2%
computed by olivLawTTM to 30 Jun 2026 · balance sheet at 30 Jun 2026
Dividend yield
unavailable
no dividend in the structured statements; a missing line is not a confirmed zero
Shareholder yield (distributions)
unavailable
input data missing

1 indicators that do not apply to the sector.

Valuation

olivLaw classification

Insufficient data
What is missing
  • indicators available: 3 of at least 6
  • score weight coverage: 18.8% of at least 60%
  • valuation methods computed: 0 of at least 1

A scoring methodology on indicators and valuation, not investment advice.

Closing price

1.50 USD

04 Nov 2026Source: olivLaw, closing series

Market cap: 11.6 m USD

Key indicators

Market capitalisation
11.6 m USD
computed by olivLawbalance sheet at 30 Jun 2026
P/E (TTM)
unavailable
insufficient data
P/B
4.2x
computed by olivLawbalance sheet at 30 Jun 2026
EV/EBITDA
unavailable
input data missing
ROE
-88.9%
computed by olivLawTTM to 30 Jun 2026 · balance sheet at 30 Jun 2026
Net margin
-680.0%
computed by olivLawTTM to 30 Jun 2026
Revenue growth (YoY)
-30.8%
computed by olivLawFY 2025
Dividend yield
unavailable
no dividend in the structured statements; a missing line is not a confirmed zero

Coverage and freshness

26/37 reporting lines present
Latest full fiscal year: 2025
Latest reported period: 30 Jun 2026
Latest balance sheet date: 30 Jun 2026
Share count (cover of the latest filing), as of: 30 Jul 2026
Source: SEC (XBRL)published 30 Jul 2026
verified 444derived 36

Score by group

19% · Insufficient data

Estimated value range

unavailable — no valuation method could be computed

Valuation assumptions are editorial choices, not measured; beta is not measured.

Valuation methods

  • DCF (discounted cash flow)unavailable · net debt missing: EV cannot be bridged to equity (missing debt is not zero)
  • Peers: EV/EBITDAunavailable · net debt missing: EV cannot be bridged to equity (missing debt is not zero)
  • Peers: P/Eunavailable · the base of the ratio is not positive
  • Dividend discount (DDM)unavailable · the company pays no dividend: a dividend model needs an explicit initiation assumption

no valuation method could be computed

Multiple comparisons use the SIC vertical: Wholesale-Drugs, Proprietaries & Druggists' Sundries (SIC 5122)

Classification (SIC) comparables group by industry code, not by economic activity; the direct group is an editorial selection by activity. Members' multiples are on their own trailing twelve months, at their own latest close.

Assumptions (illustrative, editorial)

Risk-free rate
4.3%
Equity risk premium
5.0%
Beta (default)
1.00
Cost of equity
9.3%
Terminal growth
2.5%

Factor scorecard

Insufficient data

Minimum-evidence gate: indicators available: 3 of at least 6; score weight coverage: 18.8% of at least 60%; valuation methods computed: 0 of at least 1

FactorValueScoreWeight used
ROIC · Qualityunavailableunavailable—
Net margin · Quality-680.0%13 (vs peers)33%
FCF conversion · Qualityunavailableunavailable—
Revenue CAGR 3Y · Growthunavailableunavailable—
EPS CAGR 3Y · Growthunavailableunavailable—
Net debt / EBITDA · Balance sheetunavailableunavailable—
Interest coverage · Balance sheetunavailableunavailable—
Current ratio · Balance sheet1.8x85 (on a fixed band)22%
P/E (TTM) · Valuationunavailableunavailable—
EV/EBITDA · Valuationunavailableunavailable—
FCF yield · Valuation-8.2%0 (on a fixed band)44%
Shareholder yield (distributions) · Returnsunavailableunavailable—
Payout ratio (FCF) · Returnsunavailableunavailable—

Factors without a value were dropped; the remaining weights were renormalised.

Score groups

  • Balance sheet· partial85/100 · 1/3 factors with a value
  • Growth· partialunavailable · 0/2 factors with a value
  • Quality· partial13/100 · 1/3 factors with a value
  • Returns· partialunavailable · 0/2 factors with a value
  • Valuation· partial0/100 · 1/3 factors with a value

A «partial» group is computed from under half of its weight or from one factor: it is not a full assessment of the group.

Memo

HWH INTERNATIONAL INC. (ESYN). Latest full fiscal year: 2025; data up to 2026-06-30.

Figures computed from the financial statements: revenue 866.9 k USD in 2025; YoY growth -30.8%; net margin -680.0%; ROE -88.9%.

Valuation cannot be computed from the available data.

Insufficient data for a verdict (indicators available: 3 of at least 6; score weight coverage: 18.8% of at least 60%; valuation methods computed: 0 of at least 1).

Text generated deterministically from the figures shown; no language model. Not investment advice.

What supports the thesis

  • Current ratio: 1.8x

What contradicts it

  • Net margin: -680.0%
  • FCF yield: -8.2%

Not assessed (insufficient data or a ratio without meaning): ROIC, FCF conversion, Revenue CAGR 3Y, EPS CAGR 3Y, Net debt / EBITDA, Interest coverage, P/E (TTM), EV/EBITDA, Shareholder yield (distributions), Payout ratio (FCF).

Versus the vertical median

Wholesale-Drugs, Proprietaries & Druggists' Sundries (SIC 5122) · same industry (4-digit SIC) · compared with 8 companies

Multiples and returns vs the median

P/E
—
vertical median 26.9x
EV/EBITDA
—
vertical median 16.2x
P/S
29.7x
vertical median 0.3x
above median (+9,826.3%)
P/B
4.2x
vertical median 3.8x
above median (+10.7%)
ROE
-88.9%
vertical median -16.6%
below median
Net margin
-680.0%
vertical median 0.3%
below median (−251,509.5%)
EBIT margin
—
vertical median 0.1%
Revenue YoY
-30.8%
vertical median 13.3%
below median (−332.0%)
Net debt/EBITDA
—
vertical median 0.6x
Dividend yield
—
vertical median 0.7%

Price rebased to 100 (monthly, 5 years)

Companies in the vertical

Market capP/EROENet marginRevenue YoY1A / 3A
MCKMcKESSON CORPORATION123.5 bn27.5—1.1%+12.4%+21% / +127%
CORCencora, Inc.67.6 bn26.3104.3%0.8%+9.3%−4% / +74%
CAHCardinal Health, Inc.60.9 bn36.2—0.7%+14.2%+23% / +145%
HLFHerbalife Ltd.1.6 bn9.1—3.4%+0.9%+20% / +19%
NUSNu Skin Enterprises, Inc.242.9 m—-32.5%-15.7%−14.3%−50% / −71%
COSMCosmos Health Inc.33.0 m—-104.0%-33.1%+19.9%−49% / −69%
HKPDCellyan Biotechnology Co., Ltd30.2 m—-0.6%-0.1%+21.7%+87% / unavailable
ESYNHwh International Inc.11.6 m—-88.9%-680.0%−30.8%−17% / −97%
MEDSDataMeds AI, Inc.4.6 m——-1,100.3%+28.7%−95% / unavailable

1- and 3-year price returns: for ESYN from daily closes (the same as the performance table), for the other companies from month-end closes.

olivLaw engine forecast

The world engine ran after the company's latest material disclosure. Probabilities are of TOUCHING a level within the horizon (not closing there) and sit next to the random walk (p_rw), the no-information benchmark.

The engine has no published run for this company yet.

Valuation scenarios (editable assumptions)

Illustrative scenarios

Illustrative: not forecasts and without probabilities. Each case is one coherent set of assumptions, computed on today's figures.

Bear
Allowed range: -50 … 50%
Allowed range: -100 … 100%
Allowed range: 0 … 100
Allowed range: -10 … 20%
Allowed range: 0 … 100%
Base
Allowed range: -50 … 50%
Allowed range: -100 … 100%
Allowed range: 0 … 100
Allowed range: -10 … 20%
Allowed range: 0 … 100%
Bull
Allowed range: -50 … 50%
Allowed range: -100 … 100%
Allowed range: 0 … 100
Allowed range: -10 … 20%
Allowed range: 0 … 100%
Nothing is saved.

Estimated price (USD)

Estimated priceBearBaseBull
1 years
insufficient data
Total return unavailable · Per year unavailable
insufficient data
Total return unavailable · Per year unavailable
insufficient data
Total return unavailable · Per year unavailable
3 years
insufficient data
Total return unavailable · Per year unavailable
insufficient data
Total return unavailable · Per year unavailable
insufficient data
Total return unavailable · Per year unavailable
5 years
insufficient data
Total return unavailable · Per year unavailable
insufficient data
Total return unavailable · Per year unavailable
insufficient data
Total return unavailable · Per year unavailable
What moves the 3-year price the most

    AI analysis

    AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.

    In brief

    HWH International is a small company that operates, in essence, a single café in Singapore and is developing the Hapi Marketplace e-commerce platform and the Hapi Wealth Builder education program. Revenue fell sharply in 2025 after several cafés were closed, and the company relies on funding from its majority shareholder, which raises questions about continuity of operations.

    SWOT

    Strengths

    • Financial support from the majority shareholder, which has committed to provide additional funding and not demand repayment within a set period, gives the company some operational stability.
    • The in-person café model and the digital platform could support each other, both for attracting customers and for selling affiliates' products.
    • The cost structure is lean, with few staff and some services provided by the shareholder at no direct cost.

    Weaknesses

    • Revenue is concentrated in a single café and has fallen considerably, which makes the company vulnerable to any local problem.
    • The company shows a working capital deficit and repeated net losses, and the documents flag substantial doubt about its ability to continue operations.
    • Dependence on a majority shareholder for funding and staff limits the company's independence in decision-making.

    Opportunities

    • A successful launch of Hapi Marketplace in several countries could open new revenue sources and reduce reliance on cafés.
    • The Hapi Wealth education programs could attract participants interested in financial education if the regional rollout takes place in 2026.
    • Acquisitions of complementary businesses, if they can be financed, could widen the range of services offered to customers.

    Threats

    • If funding from the majority shareholder changes, the company could be forced to reduce activity or scale back its expansion plans.
    • Competition in online commerce and the café industry could worsen the company's position, given the scale of much larger competitors.
    • Regulatory changes for financial education and for importing products could delay or burden the planned launches.

    Risks

    • Continuity of operationshigh

      The documents show substantial doubt about the company's ability to continue operating without additional capital or more stable revenue.

    • Dependence on the majority shareholderhigh

      Funding and staff come largely from the majority shareholder, which could change financing terms or the company's strategy.

    • Geographic concentrationmedium

      Almost all revenue in the first half of 2026 came from Singapore, so a local problem could affect the entire revenue flow.

    • Delayed launchesmedium

      Hapi Marketplace and the education programs depend on licences, payment systems and partners, and delays could postpone expected revenue.

    • Nasdaq listing requirementslow

      The company received notices in the past regarding market value and share price, and the risk of failing listing requirements remains relevant.

    Investment thesis

    What would need to be true (bull case)

    • If the Hapi Marketplace platform is launched successfully in several countries, the company could diversify its revenue sources and reduce dependence on a single café.
    • Steady support from the majority shareholder could keep operations running during the transition until the new businesses gain traction.
    • The integrated model of café, community and education could build a loyal customer base if the education programs are launched successfully.

    What would break the thesis

    • Revenue has fallen in recent years and in the first half of 2026, and the closure of several cafés shows difficulty in sustaining a profitable business model.
    • The documents flag substantial doubt about continuity of operations, which could force the company to reduce activity or accept harsher financing terms.
    • Dependence on a single shareholder and a single market makes the company vulnerable, and the new projects do not yet have demonstrated revenue.

    What to watch

    • Revenue trend of the Singapore café and resumption of quarterly reportingQ3 2026
    • Timing of the actual launch of Hapi Marketplace in the United States and expansion into South Korea and Hong Kong2026
    • Progress of the Hapi Wealth program and partner collaborations in the targeted regions2026
    • Terms of extension or refinancing of the shareholder credit line, maturing in April 2026next 10-K

    Products, market & competition

    AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.

    The business

    HWH International Inc. was originally incorporated in Delaware in October 2021 under the name Alset Capital Acquisition Corp. and changed its name to HWH International after completing the business combination in January 2024. The company reorganised into Nevada in November 2025, with no impact on its consolidated financial position. Its core activity remains food and beverage, which accounted for approximately 100% of revenue in 2025, and it describes itself as an early-stage company with a small number of employees.

    The company plans to extend its model through Hapi Marketplace, a business-to-consumer platform launched in November 2024 with over forty-seven product categories, which it intends to expand gradually into South Korea, Hong Kong and other Asian markets. The launch depends on logistical matters such as payment systems, licences, bank set-up and import licences, and as of June 30, 2026 the project had not yet been launched.

    The third component is Hapi Wealth Builder and the Hapi Wealth program, focused on education in equity investment and wealth-building strategies, with a rollout targeted in selected regions later in 2026. Management justified closing several cafés by citing unsustainable revenue and presented the sale of 70% of Alset F&B One as part of refocusing resources on other F&B ventures with greater growth potential.

    Segments

    Food and beverage (Hapi Café)

    This is the only segment generating revenue. Revenue was 866,926 USD in 2025 compared with 1,253,577 USD in 2024, and in the second quarter of 2026 it was only 64,200 USD, against 310,391 USD in the same period of 2025, following the closure of cafés in Korea and other locations.

    Hapi Marketplace platform

    The business-to-consumer platform is still in development, with no revenue reported in the documents. The company sees it as a channel for widening its customer base and increasing the amounts customers spend on its affiliates' products.

    Hapi Wealth Builder and Hapi Wealth

    The education programs are in the phase of producing digital content and collaborating with partners. The rollout targeted in selected regions in 2026 does not yet generate reported revenue.

    Market context

    The company operates in the café and food market in Singapore and South Korea, where Hapi Cafés are designed as in-person social experiences. Management believes that after the pandemic people seek physical communities, and this could support the model, although recent performance has been weak, with revenue falling from 1,253,577 USD in 2024 to 866,926 USD in 2025.

    Hapi Marketplace and the education programs target consumers interested in wellness, elderly care, auto accessories and financial education, a segment where competition is broad. The documents reviewed do not provide the size of this market or the company's market share.

    Trends

    • Closure of unprofitable cafésmixed

      Concentrating on a few locations and withdrawing from markets with weak revenue could reduce short-term losses, but it also shrinks the existing revenue base, which fell considerably in 2025 and the first half of 2026.

    • Digital expansion of Hapi Marketplacetailwind

      If the launch in the United States and expansion across Asia proceed, the platform could open new revenue sources from online sales, although the project depends on completing logistical and regulatory steps.

    • Dependence on shareholder fundingheadwind

      Credit lines and debt conversions from the majority shareholder have supported operations, but they can limit the company's autonomy and influence the terms of future financing.

    • Demand for in-person communitiesmixed

      Demand for physical and community experiences after the pandemic could support cafés and education programs with a meeting component, if these events can be sustained economically.

    Competitive position

    The documents reviewed do not identify direct competitors or compare the company's market share with other players. Competitive risk is described in general terms, referring to much larger competitors without naming any companies.

    The company states it aims to compete through its member community, membership discounts and cross-selling among companies in its group, advantages that depend however on its ability to attract skilled personnel and control expenses.

    • Large online retail and general retail companies

      The documents mention in general terms much larger competitors, without naming them.

    • Cafés and food chains in Singapore and South Korea

      Local competition in the café segment is not detailed in the sources reviewed, and the company closed several locations because of weak performance.

    • Financial education platforms and investment programs

      The Hapi Wealth program competes with providers of courses and coaching, not named in the document.

    • Suppliers of wellness products and elderly care

      The product categories on Hapi Marketplace face competitors in online commerce, referred to generically in the documents.

    News & filings

    In the press

    No news in our archive over the last 180 days.

    SEC filings

    • Proxy statement27 Oct 2026
    • Current report18 Sept 2026
      Amendments to articles or bylaws · Financial statements and exhibits
    • Current report11 Sept 2026
      Material agreement · Other events · Financial statements and exhibits
    • Current report01 Sept 2026
      Departure or appointment of officers · Other events · Financial statements and exhibits
    • Current report10 Aug 2026
      Material agreement · Item 3.02 · Item 5.01 · Departure or appointment of officers · Financial statements and exhibits
    • Quarterly report30 Jul 2026
    • Current report29 Jul 2026
      Other events
    • Current report09 Jun 2026
      Material agreement · Item 3.02 · Financial statements and exhibits
    • Current report29 May 2026
      Delisting notice
    • Current report27 May 2026
      Material agreement · Item 3.02 · Financial statements and exhibits

    Sources

    1. [1] Form 10-K, fiscal year ended 2025-12-31 · SEC / HWH International Inc. · 26 Mar 2026
    2. [2] Form 10-Q, quarter ended 2026-06-30 · SEC / HWH International Inc. · 30 Jul 2026

    Figures computed by olivLaw from SEC filings and closing prices; the qualitative analysis is AI-generated from cited sources. Not investment advice.